Meta vs Roche: Founders, CEOs and History
Meta was founded in 2004 by Mark Zuckerberg, Eduardo Saverin, Andrew McCollum and is led by Mark Zuckerberg. Roche was founded in 1896 by Fritz Hoffmann-La Roche and is led by Thomas Schinecker.
Company facts
Founders
Meta
Mark Zuckerberg
Meta possesses arguably the most scrutinized, polarizing, and dramatized founding story of the 21st century, rooted entirely in the exclusive, intensely competitive dormitory culture of Harvard University and driven by an effective, socially awkward computer p…
Eduardo Saverin
Eduardo Saverin was a Facebook co-founder and the company's first chief financial officer, but his long-term story diverged sharply from the company he helped start.
Andrew McCollum
Andrew McCollum co-founded Facebook but left the company relatively early compared with Zuckerberg and Moskovitz. After Facebook, he continued in technology and entrepreneurship, including work connected to education and startup leadership.
Dustin Moskovitz
Dustin Moskovitz co-founded Facebook and served as a key early technical and operational leader before leaving in 2008 to co-found Asana.
Chris Hughes
Chris Hughes co-founded Facebook and later became known for his work in media, politics, and public policy after leaving the company.
Roche
Fritz Hoffmann-La Roche
Fritz Hoffmann-La Roche (1868-1920) founded F. Hoffmann-La Roche & Co. in Basel on 1 October 1896, at age 28.
CEOs and their tenures
Meta
- Mark Zuckerberg2004–present
Founder, Chairman and CEO
Zuckerberg sets product and capital priorities and controls the majority of shareholder voting power through Class B shares.
Source - Eduardo Saverin2004–2005
Co-Founder
Eduardo Saverin co-founded Facebook with Mark Zuckerberg while at Harvard in 2004, providing the initial seed funding and serving as the company's first CFO and business manager.
Source
Roche
- Severin Schwan2008–2023
Chief Executive Officer
Serving as CEO from 2008 to 2023, he cemented Roche's absolute dominance in global oncology and highly advanced diagnostics before moving to Chairman of the Board.
Source - Thomas Schinecker2023–present
Chief Executive Officer
Under Schinecker, Roche returned to growth after the COVID testing decline: 2025 sales rose 7% at constant rates to ~$73.8 billion (CHF 61.5 billion) and 12 late-stage studies read out positively that year.
Source
Timeline: Meta and Roche side by side
1896Roche
F. Hoffmann-La Roche Founded in Basel
Fritz Hoffmann-La Roche founds the enterprise in Basel, Switzerland, pioneering mass-manufactured, chemically standardized prescription pharmaceuticals.
1898Roche
Commercial Breakthrough with Sirolin
Roche launches non-prescription cough syrup Sirolin, achieving widespread international distribution and financing early clinical laboratories.
1934Roche
First Industrial Synthesis of Vitamin C
Roche becomes the first company to mass-produce synthetic Vitamin C (Redoxon) at industrial scale, anchoring decades of high-margin global cash flow.
1963Roche
Launch of Valium (Diazepam)
Roche introduces Valium, which becomes the world's most widely prescribed psychotropic medication and establishes global pharmaceutical leadership.
1968Roche
Establishment of Roche Diagnostics
Roche launches its dedicated diagnostic division, laying the foundation to become the world's preeminent in-vitro diagnostics (IVD) provider.
2004Meta
Facebook launches at Harvard
Facebook launched on February 4, 2004, as a real-name student network. The product mattered because it made identity, campus trust and friend connections the core of the service before the company became a public social platform.
2007Meta
Ad platform becomes the business model
Facebook's advertising products turned user attention into a scalable commercial system. The shift mattered because the company could keep the consumer product free while charging marketers for measurable reach, targeting and conversion tools.
2008Roche
Severin Schwan becomes CEO
Severin Schwan became CEO of F. Hoffmann-La Roche in 2008. Led Roche for 14 years; handed over to Thomas Schinecker in March 2023 and became chairman.
2009Roche
Full Acquisition of Genentech for $46.8 Billion
Roche completes its historic $46.8 billion buyout of American biotechnology pioneer Genentech, securing market leadership in oncology biologics.
2012Meta
Instagram acquisition
Facebook agreed to acquire Instagram for about $1 billion in cash and stock. The deal mattered because Instagram was mobile-native at a moment when Facebook needed to prove it could survive the smartphone shift.
2012Meta
Facebook IPO
Facebook completed its initial public offering in May 2012, raising about $16 billion.
2014Meta
WhatsApp acquisition
Facebook announced a deal to acquire WhatsApp, adding a large private messaging network to a company still known mainly for public feeds.
2014Meta
Oculus acquisition
Facebook agreed to acquire Oculus VR for about $2 billion. The deal mattered because it gave the company a hardware and immersive-computing bet years before the Meta rebrand.
2018Roche
Foundation Medicine & Flatiron Health Acquisitions
Roche acquires Foundation Medicine and Flatiron Health, integrating real-world oncology data analytics and genomic profiling into personalized healthcare.
2021Meta
Facebook becomes Meta
Facebook changed its corporate name to Meta in 2021 to bring its apps and technologies under a new company brand.
2023Meta
Threads launch
Meta launched Threads in July 2023 and said the app passed 100 million sign-ups in its first five days. The launch mattered because Instagram distribution gave Meta a fast entry into real-time text conversation.
2023Roche
Acquired Telavant
F. Hoffmann-La Roche acquired Telavant for $7.1 billion. Roche paid $7.1 billion upfront for Telavant to gain US and Japan rights to the anti-TL1A antibody RVT-3101 (afimkibart) for inflammatory bowel disease.
2024Meta
$164.501B revenue
Meta reported $164.501 billion in FY2024 revenue and $62.360 billion in net income. The year mattered because AI-powered ad tools, Reels monetization and expense discipline restored confidence after the 2022 slowdown.
2025Meta
$200.966B Revenue
Meta reported $200.966B in FY2025 revenue, $60.458B in net income, $83.276B in income from operations, and 78,865 employees at year-end.
2025Roche
Group Sales Reach CHF 61.5 Billion
Under CEO Thomas Schinecker, Roche delivers group sales of ~$73.8 billion (CHF 61.5 billion), driven by ~$57.2B (CHF 47.7B) in Pharmaceuticals and ~$16.6B (CHF 13.8B) in Diagnostics.
2026Meta
Q2 2026 revenue up 28%
Meta reported Q2 2026 revenue of $60.80B, up 28%, and net income of $15.85B, down 14%, after $2.40B of legal charges and $1.18B of severance from a May 2026 headcount reduction. It narrowed 2026 capex guidance to $130-145B.
Acquisitions
Meta
- Kustomer2022$1B
- CTRL-labs2019$500M
- WhatsApp2014$19B
- Oculus VR2014$2B
- Instagram2012$1B
Roche
- PathAI2026$1.1B
- 89bio2025$3.5B
- Telavant2023$7.1B
- Carmot Therapeutics2023$2.7B
- Foundation Medicine2018$2.4B
- ForSight VISION42017Undisclosed
Questions about Meta vs Roche
Who is the CEO of Meta Platforms, Inc. and F. Hoffmann-La Roche AG?
Meta Platforms, Inc. is led by Mark Zuckerberg and F. Hoffmann-La Roche AG is led by Thomas Schinecker. Both serve as the top executive responsible for the company's strategy, operations, and financial performance.
When was Meta Platforms, Inc. founded vs F. Hoffmann-La Roche AG?
F. Hoffmann-La Roche AG was founded in 1896 — 108 years before Meta Platforms, Inc., which was founded in 2004. F. Hoffmann-La Roche AG's longer operating history gives it a deeper track record but also potentially more institutional inertia compared to the younger Meta Platforms, Inc..
How many employees does Meta Platforms, Inc. have compared to F. Hoffmann-La Roche AG?
Meta Platforms, Inc. employs approximately 75,472 people, while F. Hoffmann-La Roche AG employs approximately 112,774. F. Hoffmann-La Roche AG has the larger workforce at 112,774 employees, compared to Meta Platforms, Inc.'s 75,472. A higher headcount does not necessarily imply greater efficiency — it often reflects differences in business model (e.g., manufacturing vs. software).
Where are Meta Platforms, Inc. and F. Hoffmann-La Roche AG headquartered?
Meta Platforms, Inc. is headquartered in United States and F. Hoffmann-La Roche AG is headquartered in Switzerland. Their different home markets mean they may face different regulatory frameworks, tax regimes, and currency exposure.
Who founded Meta Platforms, Inc. and F. Hoffmann-La Roche AG?
Meta Platforms, Inc. was founded by Mark Zuckerberg, Eduardo Saverin, Andrew McCollum, Dustin Moskovitz, Chris Hughes. F. Hoffmann-La Roche AG was founded by Fritz Hoffmann-La Roche.
Which company has a longer operating history — Meta Platforms, Inc. or F. Hoffmann-La Roche AG?
F. Hoffmann-La Roche AG has been operating for approximately 130 years, making it the more established of the two companies. Meta Platforms, Inc. has been in operation for around 22 years. A longer operating history often signals greater institutional resilience and brand recognition, though it can also mean slower adaptation to new market conditions.
Figures come from each company's filings and the sources linked beside them. Amounts reported in another currency are shown in US dollars at an approximate rate and marked with ~. Back to the Meta vs Roche overview